[Zidovudine in the treatment of HIV-related thrombocytopenia. A study of 11 cases]
- PMID: 1947405
[Zidovudine in the treatment of HIV-related thrombocytopenia. A study of 11 cases]
Abstract
HIV-related thrombocytopenia sometimes requires a therapeutic choice: current therapies are similar to those applied in idiopathic thrombocytopenic purpura. Some Authors described a positive effect on platelets with Zidovudine (AZT) administration. We evaluated the efficacy of this drug in a group of 11 HIV-seropositive patients. Our results were not encouraging: increase in platelet count was obtained in a few patients only and it generally was of little importance.
Similar articles
-
HIV-seropositive thrombocytopenia: the action of zidovudine.AIDS. 1991 Nov;5(11):1351-6. AIDS. 1991. PMID: 1768384 Clinical Trial.
-
Report on a 3-year follow-up zidovudine (AZT) treatment in a group of HIV-positive patients with congenital clotting disorders.Haematologia (Budap). 1994;26(1):17-27. Haematologia (Budap). 1994. PMID: 7959371
-
[Thrombocytopenia in HIV-1 seropositive hemophiliacs].Rinsho Ketsueki. 1993 May;34(5):605-10. Rinsho Ketsueki. 1993. PMID: 8315832 Japanese.
-
HIV-related thrombocytopenia: a therapeutical update.Haematologica. 1991 Mar-Apr;76(2):141-9. Haematologica. 1991. PMID: 1937173 Review.
-
HIV-related thrombocytopenia.Immunodefic Rev. 1990;2(3):221-31. Immunodefic Rev. 1990. PMID: 2150312 Review.